Altria Group Inc【MO】株式ニュース

Altria Celebrates America by Investing in Our Growers, Communities, Employees and Iconic BrandsApril 27, 2026 3:15 PM
Business Wire
Altria Group, Inc. (Altria) (NYSE:MO) – Altria’s companies have strong American roots and relationships with farmers that date back more than 200 years. We have a long history of investing in high-quality U.S. jobs and manufacturing, supporting thriving communities and delivering billions of dollars in annual economic value. Today, we are building on that tradition, celebrating America’s 250th birthday with incremental investments in American tobacco growers, our communities, our employees and our iconic brands.

“In a time when many feel divided, America’s 250th birthday is a moment to come together and truly show up for one another in the communities we call home,” said Jennifer Hunter, Senior Vice President of Corporate Citizenship and Chief Sustainability Officer, Altria Client Services. “Altria and its family of companies have a long tradition of giving back to our communities. Together, we’re honoring this milestone by supporting American tobacco growers and creating new ways to serve the communities where we live and work.”

Over the next three years, ALCS, with funding from Philip Morris USA, will provide more than $8 million in philanthropic support to strengthen agricultural education, invest in tobacco-growing communities and continue to engage employees nationwide through service and civic participation. We plan to:

Establish endowments at the University of Kentucky Martin-Gatton College of Agriculture, Food and Environment (CAFE) and the Virginia Tech College of Agriculture and Life Sciences.

Provide donor-advised funds in tobacco-growing regions to support local community needs and future disaster-relief efforts.

Engage nearly 6,000 employees nationwide through volunteerism, charitable giving, and civic learning—creating shared stories of meaningful community impact.

About the University of Kentucky and Virginia Tech Endowments

Altria has built a strong relationship with both the University of Kentucky and Virginia Tech over the last several decades. Each university will receive a total of $2 million across the next three years to support endowed faculty chair positions to strengthen academic and extension capacity in these tobacco-growing communities.

“PM USA has a long history of working with growers and universities to support the long-term sustainability and vibrancy of tobacco farming,” said Jon Moore, President and CEO of PM USA. “These investments complement PM USA’s ongoing commercial purchases of U.S.-grown tobacco and our long-standing business relationships with American tobacco farmers. We know these universities play a vital role in advancing agriculture in the region, and as an American company based in Virginia, this is personal to us.”

“As new uses are established and tobacco markets shift, this generous gift will allow the college to continue to focus on emerging areas of innovation,” said Laura Stephenson, Vice President for Land-grant Engagement and dean of Martin-Gatton CAFE. “Tobacco is still an important part of Kentucky’s agricultural economy. Continuing to serve our growers, students and industry through research and education will help us address evolving challenges and strengthen the long-term sustainability of tobacco production.”

Our investment continues a decades-long relationship with Martin-Gatton CAFE and reflects our sustained commitment to supporting growers, research and agricultural leadership. Over the years, Altria and our subsidiaries, including PM USA, have funded burley and dark-fire tobacco research and Extension programs. Growing experts and advocates are equally important, and we’ve continued to make significant contributions to UK scholarships, graduate fellowships, faculty research support and the Kentucky Agricultural Leadership Program.

“Tobacco has played a defining role in Kentucky’s agricultural heritage for generations,” said Commissioner Jonathan Shell at the Kentucky Department of Agriculture. “While the industry continues to evolve, thousands of Kentucky farmers still rely on tobacco as an important part of their operations. This investment will help ensure we remain at the forefront of innovation, supporting growers with the research and tools they need to stay competitive and sustainable. I encourage others across the industry to join in supporting these efforts to secure a strong future for tobacco in Kentucky.”

We have a long-standing relationship with Virginia Tech, supporting research and Extension efforts within the College of Agriculture and Life Sciences that directly benefit producers. This endowment will provide long-term support for tobacco agronomy at the Southern Piedmont Agricultural Research and Extension Center (AREC), sustaining research, field trials and grower engagement across the Commonwealth of Virginia.

“This investment helps ensure Virginia Tech can continue delivering the research and Extension support that tobacco producers rely on every growing season,” said Mario Ferruzzi, dean of the College of Agriculture and Life Sciences. “By establishing long-term support for tobacco agronomy, we are strengthening our ability to serve the industry today while preparing the next generation of agricultural leaders.”

“Everything we do is focused on helping growers make better decisions in real time,” said David Reed, tobacco agronomist at Virginia Tech’s Southern Piedmont AREC. “This kind of support allows us to stay in the field, work directly with producers, and keep improving the systems they depend on.”

Investing in the Community

We are working to establish new donor-advised funds totaling $4.1 million to support local community needs and future disaster-relief efforts in PM USA’s key tobacco-growing communities in Virginia, North Carolina and Kentucky.

“We know firsthand the challenges that farmers, as well as entire farm communities face,” said Michael Manson, Vice President of Brand Management, PM USA. “Tragic natural disasters have hit the regions during recent years – including tornadoes and flooding that have destroyed family farms and entire communities. In addition to supporting local community needs, this fund can assist in supporting those impacted by future natural disasters.”

Altria’s 2026 Volunteer and Employee Contributions

To keep America’s 250th birthday celebration going, throughout the year we will engage our nearly 6,000 employees around what connects us most: service to others. Through an enterprise program that builds momentum from National Volunteer Month in April, we are creating multiple ways for employees across the country to participate in meaningful, local action that strengthens the places where we live and work. Altria aims to reach 25,000 volunteer hours annually by 2030.

The initiative will expand opportunities for employees to volunteer, donate and learn through accessible challenges and campaigns powered by the Altria Contributing Together platform. Employees will be encouraged to support causes they care about by participating in group volunteering, completing a civic learning challenge and donating funds through an enhanced matching gifts campaign. We will also celebrate in partnership with many of our national and local nonprofit and community partners.

Altria’s Profile

We have a leading portfolio of nicotine products for U.S. nicotine consumers age 21+. We are Moving Beyond Smoking® by responsibly transitioning adult smokers to a smoke-free future, competing vigorously for existing smoke-free adult nicotine consumers (ANC) and exploring new growth opportunities — beyond the U.S. and beyond nicotine (Vision). To achieve our Vision, we will pursue initiatives designed to promote the long-term welfare of our company, our stakeholders, society at large and the environment.

Our wholly owned subsidiaries include leading manufacturers of both combustible and smoke-free products. In combustibles, we own Philip Morris USA Inc. (PM USA), the most profitable U.S. cigarette manufacturer, and John Middleton Co. (Middleton), a leading U.S. cigar manufacturer. Our smoke-free portfolio includes ownership of U.S. Smokeless Tobacco Company LLC (USSTC), the leading global moist smokeless tobacco (MST) manufacturer, Helix Innovations LLC (Helix), a leading manufacturer of oral nicotine pouches, and NJOY, LLC (NJOY), an e-vapor manufacturer with products covered by marketing granted orders from the U.S. Food and Drug Administration (FDA).

Additionally, we have a majority-owned joint venture, Horizon Innovations LLC (Horizon), for the U.S. marketing and commercialization of heated tobacco stick products.

Our equity investments include Anheuser-Busch InBev SA/NV (ABI), the world’s largest brewer, and Cronos Group Inc. (Cronos), a leading Canadian cannabinoid company.

The brand portfolios of our operating companies include Marlboro®, Black & Mild®, Copenhagen®, Skoal®, on!® and NJOY®. Trademarks related to Altria referenced in this release are the property of Altria or our subsidiaries or are used with permission.

Learn more about Altria at www.altria.com and follow us on X, Facebook and LinkedIn.

Source: Altria Group, Inc.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260427960042/en/
Altria Client Services

Investor Relations

804-484-8222

Altria Client Services

Media Relations

www.altria.com/contact-us/media

Original: Altria Celebrates America by Investing in Our Growers, Communities, Employees and Iconic Brands

Altria Presents as Part of the Consumer Analyst Group of New York Conference; Reaffirms 2026 Full-Year Earnings GuidanceFebruary 18, 2026 7:00 AM
Business Wire
Altria Group, Inc. (Altria) (NYSE: MO) is participating in the Consumer Analyst Group of New York Conference in Orlando, Florida, today. Billy Gifford, Altria’s Chief Executive Officer, and Sal Mancuso, Altria’s Executive Vice President and Chief Financial Officer, will highlight the portfolio we are building to capture the growing smoke-free opportunity, discuss how we are evolving our business and capabilities to lead the U.S. nicotine space and provide more detail on our long-term growth aspirations.

Remarks and Presentation

The presentation will be webcast live on www.altria.com in a listen-only mode, beginning at approximately 1:00 p.m. Eastern Time. A copy of the business presentation, prepared remarks and a replay of the webcast will be available at www.altria.com.

2026 Full-Year Guidance

We reaffirm our guidance to deliver 2026 full-year adjusted diluted earnings per share (EPS) in a range of $5.56 to $5.72, representing a growth rate of 2.5% to 5.5% from a base of $5.42 in 2025. We expect 2026 adjusted diluted EPS growth to be weighted to the second half of the year, reflecting a progressive increase in cigarette import and export activity over the course of the year.

Our guidance contemplates:

(i) planned investments to support our contract manufacturing capabilities;

(ii) limited impact on combustible and e-vapor product volumes from illicit enforcement efforts; and

(iii) that NJOY ACE does not return to the marketplace in 2026.

Our 2026 full-year adjusted diluted EPS guidance range includes planned investments in support of our Vision, including cost savings generated from our Optimize & Accelerate initiative (Initiative), such as (i) marketplace activities in support of our smoke-free products and (ii) continued smoke-free product research, development and regulatory preparation expenses.

Our full-year adjusted diluted EPS guidance range excludes the impact of certain income and expense items that our management believes are not part of underlying operations. These items may include, for example, loss on early extinguishment of debt, restructuring charges, asset impairment charges, acquisition, disposition and integration-related items, equity investment-related special items, certain income tax items, charges associated with tobacco and health and certain other litigation items, resolutions of certain non-participating manufacturer (NPM) adjustment disputes under the Master Settlement Agreement (NPM Adjustment Items) and amortization expense associated with definite-lived intangible assets. See Schedule 1 below for the income and expense items for the full-year 2025.

Our management cannot estimate on a forward-looking basis the impact of certain income and expense items, including those items noted in the preceding paragraph, on our reported diluted EPS because these items, which could be significant, may be unusual or infrequent, are difficult to predict and may be highly variable. As a result, we do not provide a corresponding U.S. generally accepted accounting principles (GAAP) measure for, or reconciliation to, our adjusted diluted EPS guidance.

Altria’s Profile

We have a leading portfolio of nicotine products for U.S. nicotine consumers age 21+. We are Moving Beyond Smoking®, by responsibly transitioning adult smokers to a smoke-free future, competing vigorously for existing smoke-free adult nicotine consumers (ANC) and exploring new growth opportunities — beyond the U.S. and beyond nicotine (Vision). To achieve our Vision, we will pursue initiatives designed to promote the long-term welfare of our company, our stakeholders, society at large and the environment.

Our wholly owned subsidiaries include leading manufacturers of both combustible and smoke-free products. In combustibles, we own Philip Morris USA Inc. (PM USA), the most profitable U.S. cigarette manufacturer, and John Middleton Co. (Middleton), a leading U.S. cigar manufacturer. Our smoke-free portfolio includes ownership of U.S. Smokeless Tobacco Company LLC (USSTC), the leading global moist smokeless tobacco (MST) manufacturer, Helix Innovations LLC (Helix), a leading manufacturer of oral nicotine pouches, and NJOY, LLC (NJOY), an e-vapor manufacturer with products covered by marketing granted orders from the U.S. Food and Drug Administration (FDA).

Additionally, we have a majority-owned joint venture, Horizon Innovations LLC (Horizon), for the U.S. marketing and commercialization of heated tobacco stick products.

Our equity investments include Anheuser-Busch InBev SA/NV (ABI), the world’s largest brewer, and Cronos Group Inc. (Cronos), a leading Canadian cannabinoid company.

The brand portfolios of our operating companies include Marlboro®, Black & Mild®, Copenhagen®, Skoal®, on!® and NJOY®. Trademarks related to Altria referenced in this release are the property of Altria or our subsidiaries or are used with permission.

Learn more about Altria at www.altria.com and follow us on X, Facebook and LinkedIn.

Forward-Looking and Cautionary Statements

This release contains projections of future results and other forward-looking statements that are subject to a number of risks and uncertainties and are made pursuant to the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995.

Important factors that could cause actual results to differ materially from those contained in the forward-looking statements included in this release are described in our publicly filed reports, including our Annual Report on Form 10-K for the year ended December 31, 2024 and our Quarterly Report on Form 10-Q for the quarter ended March 31, 2025. These factors and risks include the following:

our inability to anticipate and respond to changes in ANC preferences and purchase behavior;

our inability to compete effectively;

the growth of the e-vapor category, including illicit disposable e-vapor products, which contributes to reductions in domestic cigarette consumption levels and shipment volume;

the impact of illicit trade in nicotine products and the sale of products designed to avoid the regulatory framework for nicotine products, each of which contribute to reductions in the consumption levels and shipment volumes of our businesses’ products;

our failure to develop and commercialize innovative products, including nicotine products that may reduce health risks relative to other nicotine products and appeal to ANCs;

changes, including in macroeconomic and geopolitical conditions (including inflation and tariffs), that result in shifts in ANC disposable income and purchasing behavior, including choosing lower-priced and discount brands or products, and reductions in shipment volumes;

unfavorable outcomes with respect to litigation proceedings or any governmental investigations, including significant monetary and non-monetary remedies and importation bans;

the risks associated with significant federal, state and local government actions, including FDA regulatory actions and inaction, and various private sector actions;

the risk that regulators, including the FDA, and courts may interpret laws, rules and regulations applicable to our operating companies’ products differently than we do;

increases in nicotine product-related taxes;

our failure to complete or manage successfully strategic relationships or transactions, including acquisitions, dispositions, joint ventures, commercial relationships and investments in third parties, or realize the anticipated benefits of such transactions;

significant changes in price, availability or quality of tobacco, other raw materials or component parts, including as a result of changes in macroeconomic, climate and geopolitical conditions;

our reliance on a few significant facilities and a small number of key suppliers, distributors and distribution chain service providers and the risks associated with an extended disruption at a facility or in service by a supplier, distributor or distribution chain service provider;

the risk that we may be required to write down goodwill and intangible assets, including trademarks and other intellectual property, due to impairment;

the risks associated with our Initiative, including risks relating to business continuity, our internal control over financial reporting and audit procedures and our ability to recognize the expected efficiencies;

the risk that we could decide, or be required, to recall products;

the various risks related to health epidemics and pandemics and the measures that international, federal, state and local governments, agencies, law enforcement and health authorities implement to address them;

our inability to attract and retain a highly skilled workforce due to the decreasing social acceptance of tobacco usage, tobacco control actions and other factors;

the risks associated with the various U.S. and foreign laws and regulations to which we are subject due to our international business operations;

the risks concerning a challenge to our tax positions, an increase in the income tax rate or other changes to federal or state tax laws;

the risks associated with legal and regulatory requirements related to climate change and other environmental sustainability matters;

disruption and uncertainty in the credit and capital markets, including risk of losing access to these markets;

a downgrade or potential downgrade of our credit ratings;

the impact of heightened focus by investors and other stakeholders on our performance relating to corporate responsibility matters;

the failure of our, or our key service providers’ or key suppliers’, information systems to function as intended, or cyber-attacks or security breaches affecting us or our key service providers or key suppliers;

our failure, or the failure of our key service providers or key suppliers, to comply with laws related to personal data protection, privacy, artificial intelligence and information security;

the risk that the expected benefits of our investment in ABI may not materialize in the expected manner or timeframe or at all; and

the risks associated with our investment in Cronos, including legal, regulatory and reputational risks and the risk that the expected benefits of the transaction may not materialize in the expected manner or timeframe or at all.

You should understand that it is not possible to predict or identify all factors and risks. Consequently, you should not consider the foregoing list to be complete. We do not undertake to update any forward-looking statement that we may make from time to time except as required by applicable law. All subsequent written and oral forward-looking statements attributable to Altria or any person acting on our behalf are expressly qualified in their entirety by the cautionary statements referenced above.

Schedule 1

ALTRIA GROUP, INC.

and Subsidiaries

Reconciliation of GAAP and non-GAAP Measures

(dollars in millions, except per share data)

(Unaudited)

Earnings

before

Income Taxes

Provision

for

Income

Taxes

Net

Earnings

Diluted

EPS

2025 Reported

$

9,389

$

2,442

$

6,947

$

4.12

NPM Adjustment Items

(20

)

(5

)

(15

)

(0.01

)

Acquisition and disposition-related items

76

10

66

0.04

Asset impairment, exit and implementation costs

2,184

263

1,921

1.14

Tobacco and health and certain other litigation items

58

14

44

0.03

Amortization of intangibles

132

22

110

0.06

ABI-related special items

95

20

75

0.04

Cronos-related special items

(5

)

—

(5

)

—

Income tax items

—

(5

)

5

—

2025 Adjusted for Special Items

$

11,909

$

2,761

$

9,148

$

5.42

While we report our financial results in accordance with GAAP, our management reviews certain financial results, including diluted EPS, on an adjusted basis, which excludes certain income and expense items, including those items noted under “2026 Full-Year Guidance” in the release. Our management does not view any of these special items to be part of our underlying results as they may be highly variable, may be unusual or infrequent, are difficult to predict and can distort underlying business trends and results. Our management believes that adjusted financial measures provide useful additional insight into underlying business trends and results and provide a more meaningful comparison of year-over-year results. Our management uses adjusted financial measures for planning, forecasting and evaluating business and financial performance, including allocating capital and other resources and evaluating results relative to employee compensation targets. These adjusted financial measures are not required by, or calculated in accordance with GAAP, and may not be calculated the same as similarly titled measures used by other companies. These adjusted financial measures should thus be considered as supplemental in nature and not considered in isolation or as a substitute for the related financial information prepared in accordance with GAAP.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260217437353/en/
Altria Client Services

Investor Relations

804-484-8222

Altria Client Services

Media Relations

804-484-8897

www.altria.com/contact-us/media

Original: Altria Presents as Part of the Consumer Analyst Group of New York Conference; Reaffirms 2026 Full-Year Earnings Guidance